Disappearing act.
- Published in:
- 2001
- By:
- Publication type:
- Editorial
Works matching DE "PHARMACEUTICAL industry mergers"
Results: 132
1
2
Novartis heads research table.
- Published in:
- Nature, 1997, v. 385, n. 6611, p. 5
- Publication type:
- Article
3
Making Up Is Hard to Do: Knowledge Acquisition Strategies and the Nature of New Product Innovation.
- Published in:
- Journal of Product Innovation Management, 2016, v. 33, n. 4, p. 472, doi. 10.1111/jpim.12298
- By:
- Publication type:
- Article
4
In This Issue.
- Published in:
- Journal of Product Innovation Management, 2016, v. 33, n. 4, p. 380, doi. 10.1111/jpim.12324_1
- By:
- Publication type:
- Article
5
Loretta Cangialosi.
- Published in:
- Financial Executive, 2011, v. 27, n. 2, p. 72
- Publication type:
- Article
6
Perpetuating the Pharmaceutical Pipeline.
- Published in:
- 2003
- By:
- Publication type:
- Interview
7
REFLECTING On a MEGA-MERGER.
- Published in:
- 2001
- By:
- Publication type:
- Interview
8
Predicting Competitive Effects from Prescription Drug Mergers: How Standard Economic Analysis Can Go Wrong.
- Published in:
- Antitrust Bulletin, 2014, v. 59, n. 3, p. 593, doi. 10.1177/0003603X1405900309
- By:
- Publication type:
- Article
9
FTC v. Lundbeck: Is Anything in Antitrust Obvious, Like, Ever?
- Published in:
- Antitrust Bulletin, 2014, v. 59, n. 3, p. 557, doi. 10.1177/0003603X1405900307
- By:
- Publication type:
- Article
10
Shire acquires NPS Pharmaceuticals for $5.2 billion.
- Published in:
- Optometry Times, 2015, v. 7, n. 2, p. 18
- Publication type:
- Article
11
Concentration via Consolidation in the Indian Pharmaceutical Industry: An Inquiry.
- Published in:
- ICFAI Journal of Mergers & Acquisitions, 2008, v. 5, n. 4, p. 51
- By:
- Publication type:
- Article
12
SETTING THE “RIGHT” GOAL: POST M&A INNOVATION PERFORMANCE AND GOAL ORIENTATION.
- Published in:
- Business: Theory & Practice, 2020, v. 21, n. 2, p. 555, doi. 10.3846/btp.2020.12083
- By:
- Publication type:
- Article
13
Acquiring Pharmaceutical Industry Assets in the UK: 1 + 1 = 1?
- Published in:
- Pharmaceutical Medicine, 2014, v. 28, n. 5, p. 245, doi. 10.1007/s40290-014-0066-2
- By:
- Publication type:
- Article
14
Developing new drugs.
- Published in:
- 2014
- Publication type:
- Opinion
15
News briefing: 18 March 2010.
- Published in:
- Nature, 2010, v. 464, n. 7287, p. 330, doi. 10.1038/464330a
- Publication type:
- Article
16
Pharmaceutical companies join forces on HIV.
- Published in:
- Nature, 2009, v. 458, n. 7241, p. 950, doi. 10.1038/458950b
- By:
- Publication type:
- Article
17
Merck strengthens drug pipeline in rival takeover.
- Published in:
- Nature, 2009, v. 458, n. 7235, p. 137, doi. 10.1038/458137a
- Publication type:
- Article
18
Boehringer Ingelheim Animal Health.
- Published in:
- Veterinary Ireland Journal, 2017, v. 7, n. 12, p. 639
- Publication type:
- Article
19
OBS Pakistan - Message from the CEO Tarek M. Khan.
- Published in:
- Pulse International, 2017, v. 18, n. 5, p. 15
- Publication type:
- Article
20
We wish to make OBS Pakistan an Institution for learning.
- Published in:
- Pulse International, 2016, v. 17, n. 11, p. 27
- By:
- Publication type:
- Article
21
News.
- Published in:
- Chemistry & Industry, 2016, v. 80, n. 4, p. 5, doi. 10.1002/cind.804_3.x
- Publication type:
- Article
22
Boosting African pharmaceuticals.
- Published in:
- Chemistry & Industry, 2015, v. 79, n. 7, p. 52, doi. 10.1002/cind.797_19.x
- Publication type:
- Article
23
Business digest.
- Published in:
- Chemistry & Industry, 2015, v. 79, n. 5, p. 19, doi. 10.1002/cind.795_5.x
- Publication type:
- Article
24
Business digest.
- Published in:
- Chemistry & Industry, 2015, v. 79, n. 3, p. 19, doi. 10.1002/cind.795_5.x
- Publication type:
- Article
25
Mergers ahoy.
- Published in:
- Chemistry & Industry, 2015, v. 79, n. 1, p. 52, doi. 10.1002/cind.791_19.x
- Publication type:
- Article
26
The Uncertainties Created by Relying on the Vague ‘Competition on the Merits’ Standard in the Pharmaceutical Sector: The Italian Pfizer/Pharmacia Case.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
27
A Comparative Study of Pre- and Post-Merger Financial Performances of Selected Pharmaceutical Companies in India.
- Published in:
- IUP Journal of Business Strategy, 2015, v. 12, n. 2, p. 7
- By:
- Publication type:
- Article
28
The Impact of Off-Patent Drug Acquisitions on Prices.
- Published in:
- 2018
- By:
- Publication type:
- journal article
29
Pfizer aborts Allergan deal.
- Published in:
- TCE: The Chemical Engineer, 2016, n. 899, p. 17
- Publication type:
- Article
30
Pfizer is world's biggest drug firm after swallowing Allergan.
- Published in:
- TCE: The Chemical Engineer, 2015, n. 894/895, p. 17
- Publication type:
- Article
31
In a rare deal, Shire buys Dyax.
- Published in:
- TCE: The Chemical Engineer, 2015, n. 894/895, p. 7
- Publication type:
- Article
32
Teva buying Allergan Generics for US$40.5bn.
- Published in:
- TCE: The Chemical Engineer, 2015, n. 891, p. 8
- Publication type:
- Article
33
Pfizer to buy Hospira in US$17bn deal.
- Published in:
- TCE: The Chemical Engineer, 2015, n. 885, p. 6
- Publication type:
- Article
34
Actavis buys Botox maker Allergan for US$66bn.
- Published in:
- TCE: The Chemical Engineer, 2014, n. 882, p. 8
- Publication type:
- Article
35
UK must ward off pharmageddon.
- Published in:
- TCE: The Chemical Engineer, 2014, n. 876, p. 3
- By:
- Publication type:
- Article
36
Sun Pharma buys Ranbaxy for US$4bn.
- Published in:
- TCE: The Chemical Engineer, 2014, n. 875, p. 12
- Publication type:
- Article
37
Actavis buys Forest for US$25bn.
- Published in:
- TCE: The Chemical Engineer, 2014, n. 873, p. 8
- Publication type:
- Article
38
Pharma consolidation continues.
- Published in:
- TCE: The Chemical Engineer, 2010, n. 826, p. 6
- Publication type:
- Article
39
Fourth time lucky: Roche seals deal on Genentech merger.
- Published in:
- TCE: The Chemical Engineer, 2009, n. 814, p. 5
- Publication type:
- Article
40
Merck and Schering-Plough to merge.
- Published in:
- TCE: The Chemical Engineer, 2009, n. 814, p. 5
- Publication type:
- Article
41
Takeda buys Millennium Pharma.
- Published in:
- TCE: The Chemical Engineer, 2008, n. 803, p. 8
- Publication type:
- Article
42
A shortage link?
- Published in:
- Nature Medicine, 2011, v. 17, n. 7, p. 761, doi. 10.1038/nm0711-761b
- By:
- Publication type:
- Article
43
So Tell Me Again, Why Are We Doing This?
- Published in:
- Bio-IT World, 2010, v. 9, n. 1, p. 12
- By:
- Publication type:
- Article
44
Roche buys $1 billion majority stake in Foundation.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 3, p. 155, doi. 10.1038/nrd4568
- By:
- Publication type:
- Article
45
Market watch: Biopharma deal-making in 2014: a record year for M&A value.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 2, p. 84, doi. 10.1038/nrd4536
- By:
- Publication type:
- Article
46
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 2, p. 91, doi. 10.1038/nrd3947
- Publication type:
- Article
47
Deal watch: Biogen acquires Stromedix to pursue novel fibrosis therapy.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 4, p. 260, doi. 10.1038/nrd3708
- By:
- Publication type:
- Article
48
The impact of mergers on pharmaceutical R&D.
- Published in:
- 2011
- By:
- Publication type:
- journal article
49
Modifying protein misfolding.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 11, p. 825, doi. 10.1038/nrd3316
- By:
- Publication type:
- Article
50
Luciano Rossetti.
- Published in:
- 2010
- By:
- Publication type:
- Interview